GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Holdings Corp (XKRX:096760) » Definitions » Selling and Marketing Expense

JW Holdings (XKRX:096760) Selling and Marketing Expense : ₩55,721 Mil (TTM As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is JW Holdings Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. JW Holdings's Selling and Marketing Expense for the three months ended in Sep. 2024 was ₩14,044 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₩55,721 Mil.

JW Holdings Selling and Marketing Expense Historical Data

The historical data trend for JW Holdings's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Holdings Selling and Marketing Expense Chart

JW Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66,974.73 53,853.95 51,825.44 64,714.65 58,919.52

JW Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,849.52 14,643.42 13,518.09 13,514.67 14,044.33

JW Holdings Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩55,721 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Holdings Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of JW Holdings's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Holdings Corp (XKRX:096760) » Definitions » Selling and Marketing Expense
Comparable Companies
XKRX:293480 XKRX:001630 XKRX:007570 XKRX:003060 XKRX:271980 XKRX:084110 XKRX:102460 XKRX:256840 XKRX:016580 XKRX:000020 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
698 Sindaebang 1-dong, Dongjak-gu, Seoul, KOR, 156-010
Website
http://www.jw-holdings.co.kr
JW Holdings Corp is a healthcare solutions provider. It is a drug manufacturer based in Korea and its key focus areas are raw material, completion medicine, medical supplies and medical appliances. The company's array of products comprises of antimicrobials, antifungals, anticancer and gastrointestinal agents. It licenses and markets in its home country and in regions such as United States, Japan, Germany, and China.

JW Holdings Headlines

No Headlines